COG vs. KOO, RENX, FDBK, INHC, TRLS, IQAI, DVRG, SENS, EMIS, and CRW
Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Kooth (KOO), Renalytix (RENX), Feedback (FDBK), Induction Healthcare Group (INHC), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.
Cambridge Cognition vs.
Cambridge Cognition (LON:COG) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.
35.2% of Cambridge Cognition shares are held by institutional investors. Comparatively, 65.0% of Kooth shares are held by institutional investors. 29.9% of Cambridge Cognition shares are held by company insiders. Comparatively, 17.3% of Kooth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Cambridge Cognition received 93 more outperform votes than Kooth when rated by MarketBeat users. However, 92.31% of users gave Kooth an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.
Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.
Kooth has a net margin of 7.89% compared to Cambridge Cognition's net margin of -10.07%. Kooth's return on equity of 18.59% beat Cambridge Cognition's return on equity.
In the previous week, Cambridge Cognition's average media sentiment score of 0.00 equaled Kooth'saverage media sentiment score.
Kooth has a consensus price target of GBX 583.33, suggesting a potential upside of 343.60%. Given Kooth's stronger consensus rating and higher possible upside, analysts plainly believe Kooth is more favorable than Cambridge Cognition.
Cambridge Cognition has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Kooth has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
Summary
Kooth beats Cambridge Cognition on 12 of the 16 factors compared between the two stocks.
Get Cambridge Cognition News Delivered to You Automatically
Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cambridge Cognition Competitors List
Related Companies and Tools
This page (LON:COG) was last updated on 3/29/2025 by MarketBeat.com Staff